ALKS

Alkermes plc. ALKS

NasdaqMid CapHealthcare
InternationalScored off the official board: an annual-only filer, so this data lags a domestic quarterly filer.

13F Pro quality score

Rank #1,653 of 2,925

Why it scores 50Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$496.01M

Quarter to Jun 30

Net income

$501.0K

Quarter to Jun 30

Free cash flow

$137.04M

Quarter to Jun 30

Operating margin

3.7%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$9.31B total
BlackRock, Inc.
$1.53B+3.3%
BAKER BROS. ADVISORS LP
$524.59M0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC
$497.27M-0.2%
STATE STREET CORP
$479.97M-3.2%
VANGUARD CAPITAL MANAGEMENT LLC
$393.75M+1.2%
PRICE T ROWE ASSOCIATES INC /MD/
$353.00M+44.4%
RENAISSANCE TECHNOLOGIES LLC
$338.52M+4.9%
GEODE CAPITAL MANAGEMENT, LLC
$234.66M+7.1%
DIMENSIONAL FUND ADVISORS LP
$219.79M-7.2%
Deep Track Capital, LP
$209.58M+11.4%
AMERICAN CENTURY COMPANIES INC
$207.18M-34.9%
Holocene Advisors, LP
$188.70M+55.4%
Commodore Capital LP
$157.19M-28.6%
WELLINGTON MANAGEMENT GROUP LLP
$147.48M-5.2%
PRIMECAP MANAGEMENT CO/CA/
$132.49M-0.4%
FIRST TRUST ADVISORS LP
$126.85M-18.5%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$122.35M+4.4%
Nuveen, LLC
$121.78M-5.5%
NORGES BANK
$113.01M--
BVF INC/IL
$112.90M+7.7%
GOLDMAN SACHS GROUP INC
$106.05M+7.5%
Bain Capital Life Sciences Investors, LLC
$101.54M+217.7%
NORTHERN TRUST CORP
$95.97M+7.9%
MORGAN STANLEY
$91.79M+0.9%
RTW INVESTMENTS, LP
$87.62M0.0%
See all 426 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Operating Margin

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Debt/Equity

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/ALKS

Earnings Per Share

13fpro.ai/company/ALKS

Loading ratio trend…

Companies similar to ALKS

Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.

ALKS insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

Congress trading in ALKS

2 transactions in ALKS reported by 1 member of Congress under the STOCK Act, most recent trade Sep 29, 2026. Reported transactions, not recommendations.

All Congress stock trades →

About Alkermes plc. (ALKS): stock profile, AI score and financials

Alkermes plc. (ALKS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ALKS at 49.8/100 on a composite quality score built from its SEC filings, placing it at rank #1,653 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Alkermes plc. reports quarterly revenue of $496.0M, net income of $501.0K, an operating margin of 3.7%. ALKS trades on the Nasdaq exchange and files with the SEC under CIK 1520262. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ALKS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Alkermes plc. directly from SEC EDGAR.

SEC EDGAR: CIK 1520262 →